Labcorp LH recently announced the launch and national availability of its blood biomarker test, Amyloid-Tau-Neurodegeneration (“ATN”) Profile. Physicians can now use the test with patients who are ...
Labcorp (NYSE:LH) on Wednesday announced the latest addition to its Alzheimer's testing portfolio: The pTau217 test, designed to identify phosphorylated tau 217 (pTau217), a key blood-based biomarker ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback